Literature DB >> 28059471

Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies.

Daniel Erskine1,2, Alan J Thomas3, Johannes Attems1, John-Paul Taylor3, Ian G McKeith3, Christopher M Morris1,2, Ahmad A Khundakar1.   

Abstract

BACKGROUND: Complex visual hallucinations occur in 70%-80% of dementia with Lewy bodies patients and significantly affect well-being. Despite the prevalence of visual hallucinations in dementia with Lewy bodies, the neuropathological basis of this phenomenon is poorly understood. The pulvinar nucleus of the thalamus has not previously been neuropathologically examined, but has been linked to visual hallucinations in dementia with Lewy bodies. The objective of this study was to investigate whether neuropathological or morphometric changes occur in the pulvinar nucleus in dementia with Lewy bodies cases that may contribute to visual hallucinations.
METHODS: Postmortem pulvinar tissue was acquired from 8 individuals with dementia with Lewy bodies, 8 with Alzheimer's disease, and 8 control cases and was analyzed using stereological and quantitative neuropathological techniques.
RESULTS: Lewy body pathology was present throughout the pulvinar in dementia with Lewy bodies but was most severe in the medial pulvinar. Neuronal loss was found in the lateral pulvinar in dementia with Lewy bodies and Alzheimer's disease but was more severe in dementia with Lewy bodies.
CONCLUSIONS: The pulvinar has an important role in visual attention, visual target selection and affective visual perception. These functions are thought to be deficient in dementia with Lewy bodies and may contribute a vulnerability to visual hallucinations. Therefore, this study has demonstrated neuropathological changes that may promote the manifestation of visual hallucinations in dementia with Lewy bodies.
© 2017 International Parkinson and Movement Disorder Society. © 2017 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Lewy body; dementia; pulvinar; stereology; synuclein; thalamus

Mesh:

Year:  2017        PMID: 28059471     DOI: 10.1002/mds.26887

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  7 in total

Review 1.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 2.  Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction.

Authors:  Marco Onofrj; Alberto J Espay; Laura Bonanni; Stefano Delli Pizzi; Stefano L Sensi
Journal:  Mov Disord       Date:  2019-07-15       Impact factor: 10.338

3.  Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.

Authors:  Daniel Erskine; John-Paul Taylor; Alan Thomas; Daniel Collerton; Ian McKeith; Ahmad Khundakar; Johannes Attems; Christopher Morris
Journal:  Neurosci Bull       Date:  2019-02-06       Impact factor: 5.203

4.  Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies.

Authors:  Daniel Erskine; Jinhui Ding; Alan J Thomas; Alice Kaganovich; Ahmad A Khundakar; Peter S Hanson; John-Paul Taylor; Ian G McKeith; Johannes Attems; Mark R Cookson; Christopher M Morris
Journal:  Mov Disord       Date:  2018-03-23       Impact factor: 10.338

5.  Low Pulvinar Intensity in Susceptibility-Weighted Imaging May Suggest Cognitive Worsening After Deep Brain Stimulation Therapy in Patients With Parkinson's Disease.

Authors:  Keita Matsuura; Masayuki Maeda; Masayuki Satoh; Ken-Ichi Tabei; Tomohiro Araki; Maki Umino; Hiroyuki Kajikawa; Naoko Nakamura; Hidekazu Tomimoto
Journal:  Front Neurol       Date:  2019-10-31       Impact factor: 4.003

6.  Association between clinical symptoms and post-mortem neuropathology in dementia with Lewy bodies.

Authors:  Yoshitsugu Kaneko; Kentaro Hirao; Shuntaro Serisawa; Hidekazu Kanetaka; Soichiro Shimizu; Hideaki Hirai; Yukiko Shishido-Hara; Takahiko Umahara; Hirofumi Sakurai; Haruo Hanyu
Journal:  Geriatr Gerontol Int       Date:  2020-03       Impact factor: 2.730

Review 7.  Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty.

Authors:  Alexandru Vasincu; Răzvan-Nicolae Rusu; Daniela-Carmen Ababei; Mădălina Larion; Walther Bild; Gabriela Dumitrița Stanciu; Carmen Solcan; Veronica Bild
Journal:  Biology (Basel)       Date:  2022-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.